Latest Regulatory Filings News

Lincoln Minerals has identified multiple high-priority drill targets at its Minbrie Copper-Base Metals Project in South Australia, with drilling approvals advancing for a campaign planned in the second half of 2025.

Laramide Resources has expanded its private placement to raise up to $12 million, aiming to fast-track US permitting and strengthen its balance sheet. The move signals confidence in advancing its late-stage uranium projects amid a competitive market.

Capricorn Metals capped FY25 with a strong Q4 at Karlawinda, delivering gold production at the upper guidance range while pushing forward major development milestones.

Aguia Resources has successfully closed its Share Purchase Plan, raising approximately $649,200 through the issuance of over 18 million new shares. This capital injection supports the company’s phosphate and gold projects in Brazil and Colombia.

Findi Limited is applying for two key licences from the Reserve Bank of India to expand its digital payments footprint, aiming to bridge the gap between cash and digital economies across India.

Neurizon Therapeutics has inked a pivotal global licensing deal with Elanco Animal Health, unlocking critical intellectual property and data to accelerate the development and commercialisation of its lead drug candidate NUZ-001 for neurodegenerative diseases including ALS.

EMVision Medical Devices has activated five of six pivotal trial sites for its emu™ bedside brain scanner, advancing towards FDA clearance while launching a parallel innovation study in Australia.

Tlou Energy has admitted to a late filing of a key director interest notice for its former Managing Director, prompting an ASX inquiry into its compliance processes. The company vows to tighten internal controls following the breach.

Echo IQ has initiated a pivotal clinical validation study with the Mayo Clinic Platform to test its EchoSolv HF software, marking the final step before its planned FDA submission in late 2025.

Mesoblast has secured FDA agreement on key requirements for its Biologics License Application for Revascor, targeting ischemic heart failure patients with reduced ejection fraction. The company aims for accelerated approval by year-end 2025.

West Cobar Metals has initiated approvals for a 5,000m air core drilling campaign at its promising Mystique Gold Project, aiming to unlock significant gold mineralisation in Western Australia’s Fraser Range.

Optiscan Imaging Ltd has commenced a landmark clinical study at Royal Melbourne Hospital, testing its cutting-edge InVue® and InForm™ devices to improve breast cancer surgery precision. The study aims to generate critical data for US FDA approval and could redefine surgical oncology workflows.